SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-019998
Filing Date
2020-08-03
Accepted
2020-08-03 20:54:59
Documents
1
Period of Report
2020-08-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2162
  Complete submission text file 0001213900-20-019998.txt   3485
Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
BOESS CARSTEN (Reporting) CIK: 0001277495 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39421 | Film No.: 201070737

Mailing Address 412 WEST 15TH STREET, FLOOR 9 NEW YORK NY 10011
Business Address 412 WEST 15TH STREET, FLOOR 9 NEW YORK NY 10011 646-343-9298
Health Sciences Acquisitions Corp 2 (Issuer) CIK: 0001814114 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 6770 Blank Checks
Office of Real Estate & Construction